University of Iowa researcher Michael Welsh, MD, is one of four researchers who will receive the 21st annual Wiley Prize in Biomedical Sciences for discoveries leading to the creation of cystic fibrosis (CF) treatments that have improved—and extended—the lives of patients living with CF.  

Welsh, professor of internal medicine at the University of Iowa Carver College of Medicine and director of the UI Pappajohn Biomedical Institute, will share the award with Paul Negulescu, Fredrick Van Goor, and Sabine Hadida from Vertex Pharmaceuticals, for research and development leading to medicines that effectively treat CF. The treatments work by correcting the folding, trafficking, and functioning of the mutated cystic fibrosis transmembrane regulator (CFTR).

Read more here.